Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
event decrease » cement decreases (Expand Search), levels decreased (Expand Search)
point decrease » point increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
event decrease » cement decreases (Expand Search), levels decreased (Expand Search)
point decrease » point increase (Expand Search)
-
3861
-
3862
-
3863
-
3864
-
3865
Differences in mean scores of upper extremity performance in all five accelerometer-derived variables across four time points- pre-HABIT, post-HABIT, 3-month, and 6-month post-HABI...
Published 2024“…The trends seen in the line graphs above indicate a decrease in all the accelerometer derived variables at 3-month time point (except use ratio) suggesting decrease in bimanual performance. …”
-
3866
Analysis of stress-related gene expression in cherry shrimp (<i>N</i>. <i>davidi</i> var. red).
Published 2024Subjects: -
3867
-
3868
-
3869
-
3870
-
3871
-
3872
-
3873
-
3874
Effects of ABZ on the viability of <i>M. corti.</i>
Published 2025“…Viability was not significantly affected for at least 3 days, and then decreased to 38% and 10% for ABZ 1 µM and 10 µM, respectively, by day 10. …”
-
3875
-
3876
Table1_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.docx
Published 2024“…The risk of AEs such as decreased platelet count, anemia, decreased white blood cell count, pneumonitis, asthenia, and edema caused by pralsetinib is significantly higher than that of selpercatinib. …”
-
3877
Image2_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.TIF
Published 2024“…The risk of AEs such as decreased platelet count, anemia, decreased white blood cell count, pneumonitis, asthenia, and edema caused by pralsetinib is significantly higher than that of selpercatinib. …”
-
3878
Table2_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.docx
Published 2024“…The risk of AEs such as decreased platelet count, anemia, decreased white blood cell count, pneumonitis, asthenia, and edema caused by pralsetinib is significantly higher than that of selpercatinib. …”
-
3879
Image1_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.TIF
Published 2024“…The risk of AEs such as decreased platelet count, anemia, decreased white blood cell count, pneumonitis, asthenia, and edema caused by pralsetinib is significantly higher than that of selpercatinib. …”
-
3880
Minimal data set.
Published 2024“…In contrast, with a negative Soret coefficient, the growth rate of the spherical crystals increases as the coefficient decreases, and the solute concentration near the interface decreases. …”